Blood Pressure-lowering treatment with candesartan in patients with acute hemorrhagic stroke

Stroke

Volumn 45, Issue 11, 2014, Pages 3440-3442

  Jusufovic, Mirza ^a   Sandset, Else C ^a   Bath, Philip M W ^b   Berge, Eivind ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Angiotensin receptor antagonists; Blood pressure; Intracranial hemorrhages; Monitoring, ambulatory

Indexed keywords

CANDESARTAN; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

AGED; BLOOD PRESSURE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CONFERENCE PAPER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SYSTOLIC BLOOD PRESSURE; INTRACRANIAL HEMORRHAGES; MIDDLE AGED; STROKE; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; STROKE; TETRAZOLES; TREATMENT OUTCOME;

EID: 84920278321     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.006433     Document Type: Conference Paper

References (12)

1. Morgenstern LB, Hemphill JC III, Anderson C, Becker K, Broderick JP, Connolly ES Jr, et al; American Heart Association Stroke Council and Council on Cardiovascular Nursing. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108-2129.
2. Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Hussein HM, et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25:32-38.
3. Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355-2365.
4. Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lu¨ders S, et al; SCAST Study Group. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011;377:741-750.
5. Sandset EC, Murray G, Boysen G, Jatuzis D, Kõrv J, Lu¨ders S, et al; SCAST Study Group. Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised-and placebo-controlled clinical trial (NCT00120003). Int J Stroke. 2010;5:423-427.
6. Arima H, Huang Y, Wang JG, Heeley E, Delcourt C, Parsons M, et al; INTERACT1 Investigators. Earlier blood pressure-lowering and greater attenuation of hematoma growth in acute intracerebral hemorrhage: INTERACT pilot phase. Stroke. 2012;43:2236-2238.
7. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004;43:18-24.
8. Dowlatshahi D, Demchuk AM, Flaherty ML, Ali M, Lyden PL, Smith EE; VISTA Collaboration. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology. 2011;76:1238-1244.
9. Anderson CS, Huang Y, Arima H, Heeley E, Skulina C, Parsons MW, et al; INTERACT Investigators. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke. 2010;41:307-312.
10. Schrader J, Lu¨ders S, Kulschewski A, Berger J, Zidek W, Treib J, et al; Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke. 2003;34:1699-1703.
11. The ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (enos) trial (isrctn99414122). Int J Stroke. 2006;1:245-249.
12. Qureshi AI, Palesch YY. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15:559-576.